AASLD: New PI Effective, Safe in HCV Trial (CME/CE)
SAN FRANCISCO (MedPage Today) — An investigational hepatitis C drug was safe and effective in a small randomized trial, a researcher said here.
Article printed from Gastroenterology Education and CPD for trainees and specialists: https://www.gastrotraining.com